TY  - JOUR
AU  - Schetters, Sjoerd T T
AU  - Kruijssen, Laura J W
AU  - Crommentuijn, Matheus H W
AU  - Kalay, Hakan
AU  - Ochando, Jordi
AU  - den Haan, Joke M M
AU  - Garcia-Vallejo, Juan J
AU  - van Kooyk, Yvette
PY  - 2018
DO  - 10.3389/fimmu.2018.00990
SN  - 1664-3224
UR  - http://hdl.handle.net/20.500.12105/8956
AB  - The efficacy of vaccination studies aimed at targeting antigens to human DC-SIGN (hDC-SIGN) have been notoriously difficult to study in vivo, as eight dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) homologs...
LA  - eng
PB  - Frontiers Media
KW  - CD209a
KW  - SIGNR5
KW  - Antigen delivery
KW  - Dendritic cell
KW  - Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin
KW  - Vaccination
KW  - Animals
KW  - Animals, Genetically Modified
KW  - Antibodies
KW  - CD4-Positive T-Lymphocytes
KW  - CD8-Positive T-Lymphocytes
KW  - Cell Adhesion Molecules
KW  - Dendritic Cells
KW  - Female
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - Humans
KW  - Lectins, C-Type
KW  - Macrophages
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Ovalbumin
KW  - Receptors, Cell Surface
KW  - Vaccination
KW  - Adaptive Immunity
KW  - Antigen Presentation
TI  - Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity
TY  - journal article
ER  -